Norges Bank Paratek Pharmaceuticals, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2023
BUY
$2.94 - $4.77 $195,804 - $317,682
66,600 New
66,600 $197,000
Q1 2022

May 09, 2022
SELL
$2.94 - $4.77 $232,848 - $377,783
-79,200 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$4.07 - $5.3 $322,344 - $419,760
79,200 New
79,200 $356,000
Q3 2021

Nov 14, 2022
BUY
$4.7 - $7.24 $501,960 - $773,232
106,800 New
106,800 $519,000
Q3 2021

Nov 05, 2021
SELL
$4.7 - $7.24 $738,840 - $1.14 Million
-157,200 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$6.81 - $10.93 $1.07 Million - $1.72 Million
157,200 New
157,200 $1.07 Million
Q1 2020

May 08, 2020
SELL
$2.67 - $4.97 $771,651 - $1.44 Million
-289,008 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$2.93 - $4.5 $846,793 - $1.3 Million
289,008 New
289,008 $1.17 Million
Q4 2019

Feb 12, 2020
SELL
$2.93 - $4.5 $846,793 - $1.3 Million
-289,008 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$3.08 - $5.76 $890,144 - $1.66 Million
289,008 New
289,008 $1.25 Million
Q3 2019

Nov 08, 2019
SELL
$3.08 - $5.76 $890,144 - $1.66 Million
-289,008 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$3.47 - $6.32 $1 Million - $1.83 Million
289,008 New
289,008 $1.15 Million
Q2 2019

Aug 09, 2019
SELL
$3.47 - $6.32 $1.66 Million - $3.01 Million
-476,977 Closed
0 $0
Q4 2018

Mar 04, 2019
BUY
$4.8 - $11.6 $2.29 Million - $5.53 Million
476,977 New
476,977 $2.45 Million
Q4 2018

Feb 08, 2019
SELL
$4.8 - $11.6 $2.29 Million - $5.53 Million
-476,977 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$9.05 - $10.95 $4.32 Million - $5.22 Million
476,977 New
476,977 $4.63 Million
Q3 2018

Nov 09, 2018
SELL
$9.05 - $10.95 $4.32 Million - $5.22 Million
-476,977 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$10.2 - $13.9 $4.87 Million - $6.63 Million
476,977 New
476,977 $4.87 Million
Q2 2018

Jul 23, 2018
SELL
$10.2 - $13.9 $4.87 Million - $6.63 Million
-476,977 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$12.65 - $18.85 $6.03 Million - $8.99 Million
476,977 New
476,977 $6.2 Million
Q1 2018

May 09, 2018
SELL
$12.65 - $18.85 $6.67 Million - $9.93 Million
-526,977 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$17.45 - $25.6 $9.2 Million - $13.5 Million
526,977 New
526,977 $9.43 Million
Q4 2017

Feb 09, 2018
SELL
$17.45 - $25.6 $9.2 Million - $13.5 Million
-526,977 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$18.9 - $28.2 $9.96 Million - $14.9 Million
526,977 New
526,977 $13.2 Million
Q3 2017

Nov 07, 2017
SELL
$18.9 - $28.2 $5.95 Million - $8.87 Million
-314,654 Closed
0 $0
Q2 2017

Jul 24, 2018
BUY
N/A
218,154 Added 226.07%
314,654 $7.58 Million
Q1 2017

May 11, 2018
BUY
N/A
75,187 Added 352.78%
96,500 $1.86 Million
Q3 2016

Nov 13, 2017
BUY
N/A
21,313
21,313 $0

Others Institutions Holding PRTK

# of Institutions
4
Shares Held
1.54M
Call Options Held
0
Put Options Held
0
View Full List

About Paratek Pharmaceuticals, Inc.

PRTK Quotes by TradingView
  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email